CoChat

Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score

Open access
Åberg, Fredrik, Luukkonen, Panu K., But, Anna, Salomaa, Veikko, Britton, Annie, Petersen, Kasper Meidahl, Bojesen, Stig Egil, Balling, Mie, Nordestgaard, Børge G., Puukka, Pauli, Männistö, Satu, Lundqvist, Annamari, Perola, Markus, Jula, Antti, Färkkilä, Martti · 2022 · Journal of Hepatology
Cited by 73

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background & Aims Current screening strategies for chronic liver disease focus on detection of subclinical advanced liver fibrosis but cannot identify those at high future risk of severe liver disease. Our aim was to develop and validate a risk prediction model for incident chronic liver disease in the general population based on widely available factors. Methods Multivariable Cox regression analyses were used to develop prediction models for liver-related outcomes with and without laboratory measures (Model lab and Model non-lab ) in 25,760 individuals aged 40–70 years. Their data were sourced from the Finnish population-based health examination surveys FINRISK 1992-2012 and Health 2000 (derivation cohort). The models were externally validated in the Whitehall II (n = 5,058) and Copenhagen City Heart Study (CCHS) (n = 3,049) cohorts. Results The absolute rate of incident liver outcomes per 100,000 person-years ranged from 53 to 144. The final prediction model included age, sex, alcohol use (drinks/week), waist–hip ratio, diabetes, and smoking, and Model lab also included gamma-glutamyltransferase values. Internally validated Wolbers' C-statistics were 0.77 for Model lab and 0.75 for Model non-lab , while apparent 15-year AUCs were 0.84 (95% CI 0.75-0.93) and 0.82 (95% CI 0.74-0.91). The models identified a small proportion (<2%) of the population with >10% absolute 15-year risk for liver events. Of all liver events, only 10% occurred in participants in the lowest risk category. In the validation cohorts, 15-year AUCs were 0.78 (Model lab ) and 0.65 (Model non-lab ) in the CCHS cohort, and 0.78 (Model non-lab ) in the Whitehall II cohort. Conclusions Based on widely available risk factors, the C hronic Liv er D isease (CLivD) score can be used to predict risk of future advanced liver disease in the general population. Lay summary Liver disease often progresses silently without symptoms and thus the diagnosis is often delayed until severe complications occur and prognosis becomes poor. In order to identify individuals in the general population who have a high risk of developing severe liver disease in the future, we developed and validated a C hronic Liv er D isease (CLivD) risk prediction score, based on age, sex, alcohol use, waist-hip ratio, diabetes, and smoking, with or without measurement of the liver enzyme gamma-glutamyltransferase. The CLivD score can be used as part of health counseling, and for planning further liver investigations and follow-up.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2022.02.021

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 73

Metadata

Authors
Åberg, F., Luukkonen, P. K., But, A., Salomaa, V., Britton, A., Petersen, K. M., Bojesen, S. E., Balling, M., Nordestgaard, B. G., Puukka, P., Männistö, S., Lundqvist, A., Perola, M., Jula, A., & Färkkilä, M.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2022-08
Volume
77
Issue
2
Pages
302-311
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4220823185
Cited by
73
References
10
FWCI
9.03
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score. https://app.cochat.ai/papers/10.1016/j.jhep.2022.02.021
The paper
Åberg, F., Luukkonen, P. K., But, A., Salomaa, V., Britton, A., Petersen, K. M., Bojesen, S. E., Balling, M., Nordestgaard, B. G., Puukka, P., Männistö, S., Lundqvist, A., Perola, M., Jula, A., & Färkkilä, M. (2022). Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2022.02.021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.